Participants from a total of sixteen
Asia-Pacific member countries (Australia, Bangladesh, Cambodia, China,
Indonesia, Lao PDR, Malaysia, Maldives, Mongolia, Philippines, Republic of
Korea, Japan, Singapore, Sri Lanka, Thailand, and Viet Nam) and experts from
Ewha Womans University (Republic of Korea), Health Insurance Review and
Assessment Services (HIRA, Republic of Korea), National Health Insurance
Service (NHIS, Republic of Korea ), University of Tokyo (Japan), University of
Newcastle (Australia), University of South Australia (Australia), and Fudan
University (China) were convened for the meeting.
Participants and experts
discussed high cost medicines, pharmaceutical policies in countries and new
pricing strategies, future activities and agenda, and the role of the network; topics
presented and discussed were as follows:
-
Regional update on access to medicines in the
Western Pacific (Socorro Escalante, WHO/WPRO)
-
Strategic purchasing
initiative in South East Asia (Klara Tisocki, WHO/SEARO)
-
Value in pharmaceutical
pricing: cross-country analysis (Luca Lorenzoni, OECD)
-
Malaysia plan for better
access to hepatitis C treatment (Kamaruzaman Saleh, Ministry of
Health/Malaysia)
-
Pricing and reimbursement
policy of similar biotherapeutic products in Korea (Dong-Sook Kim, HIRA/Korea)
-
Access to orphan drugs in
Thailand (Somruethai Supungul, NHSO/Thailand)
-
Medicines pricing and HTA in China (Yingyao Chen,
Fudan University/WHOCC/China)
-
Medicines price regulation in Sri Lanka (Kamal
Jayasinghe, Ministry of Health, Nutrition and indigenous Medicine/Sri Lanka)
-
Discussion on medicines price regulation in the
Philippines (Irene Florentino-Farinas, Department of Health/Philippines)
-
Utilisation data for evaluating access and price
setting in selected countries (Libby Roughead, University of South
Australia/Australia)
-
Risk-sharing through Managed Entry Agreements
(David Newby, University of Newcastle/Australia)
-
Overview of pharmaceutical pricing methods (Soonman
Kwon, Seoul National University/WHOCC/Korea)
-
Medicines Pricing regulation in Japan (Ataru
Igarashi, University of Tokyo/Japan)
-
The role of HTA in pricing and reimbursement of
pharmaceuticals (Seungjin Bae, Ewha Womans University/Korea)
-
On how to improve access to medicines under UHC: a
framework for analysis (Sun-Young Kim, Seoul National University/WHOCC/Korea)
Poster walk and speed
networking were conducted during the first day of the meeting. Group activities
were included in the meeting; participants discussed global debate on
cost-plus, value-based pricing and differential pricing, and future activities
and the role of the network in the second day of the meeting.
Designed by sketchbooks.co.kr / sketchbook5 board skin
Sketchbook5, 스케치북5
Sketchbook5, 스케치북5
Sketchbook5, 스케치북5
Sketchbook5, 스케치북5